Screener
Eligibility screening
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment
137 US sites in CA, FL, GA, IA +25
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment
137 US sites in CA, FL, GA, IA +25
Before we begin
Your answer affects how the questions are phrased.